# Bloodworks – FDA Inspection, Oct 14, 2011

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/0b73bc67-6322-4745-8934-4c7ed0ce0a8d
Source feed: FDA_Inspections

> FDA inspection 749837 of Bloodworks, October 14, 2011. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 749837
- Company Name: Bloodworks
- Inspection Date: 2011-10-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1312856 - 2026-04-15
- FDA Inspection 1167416 - 2022-03-15
- [FDA Inspection 1031409 - 2017-11-02](https://www.keypedia.com/records/fda_inspections/bloodworks/28b8eca4-785d-4248-8587-48b8d7d2bd53)
- [FDA Inspection 904964 - 2014-11-28](https://www.keypedia.com/records/fda_inspections/bloodworks/6767c5ba-9e35-45f9-9402-fc5be7166f6a)
- FDA Inspection 812004 - 2012-12-13

Company: https://www.keypedia.com/companies/bloodworks/30ba73e7-0146-4206-9f44-095b277a6eef

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d